Skip to content
Research/Peptides/Follistatin 315

Follistatin 315

FST315. 315-amino acid glycoprotein. Inhibits myostatin and activin A. Promotes muscle growth and fat reduction. Myostatin inhibitor, anabolic.

Intelligence Profile

Research Papers

The available research on follistatin 315 is extremely limited, with most studies focusing on related follistatin compounds rather than follistatin 315 specifically.

Muscle and Bone Effects
A 2021 mouse study examined how follistatin-induced muscle growth affects bone structure in young adult male mice, finding that increased muscle mass led to changes in bone geometry (PMID: 33869993). However, this study did not specify follistatin 315 as the compound used.

Detection Methods
One study from 2019 developed methods to detect "follistatin 344" in black market products, highlighting concerns about unregulated follistatin compounds in circulation (PMID: 31758732). This suggests follistatin variants are being used outside of approved medical contexts.

Tissue Repair Research
A 2019 in vitro and in vivo study investigated follistatin's effects on cell migration, blood vessel formation, and bone formation, as well as bone repair processes (PMID: 30881954). Again, the specific follistatin variant was not clearly identified as follistatin 315.

Other Applications
Additional research has explored follistatin in other contexts, including embryonic development in pigs (PMID: 29119699) and various cellular signaling pathways (PMID: 26735394, 26560317), but these studies do not specifically address follistatin 315.

Clinical Evidence Gap
No clinical trials specifically investigating follistatin 315 were identified in the available evidence.

The research base for follistatin 315 specifically appears very thin, with most available studies examining other follistatin variants or follistatin generally without specifying the exact compound. More research would be needed to establish the safety and efficacy profile of follistatin 315 specifically.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.